Abstracts tagged "juvenile idiopathic arthritis (JIA) and ultrasonography"

Abstract Number: 2287 • 2014 ACR/ARHP Annual Meeting
Cartilage Thickness and Bone Health in Children with Juvenile Idiopathic Arthritis
Marinka Twilt¹, Dan Pradsgaard², Anne Helene Spannow², Arne Horlyck³, Carsten Heuck² and Troels Herlin⁴, ¹Paediatrics, Aarhus University Hospital, Aarhus, Denmark, ²paediatrics, Aarhus University Hospital, Aarhus, Denmark, ³radiology, Aarhus University Hospital, Aarhus, Denmark, ⁴Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
Background/Purpose Although treatment options have increased and morbidity has decreased in the last decade Juvenile Idiopathic Arthritis (JIA) may still result in disability. Increasingly ultrasonography…
Abstract Number: 226 • 2013 ACR/ARHP Annual Meeting
Omeract Definitions For The Sonographic Appearance Of The Normal Pediatric Joint
Johannes Roth¹, Sandrine Jousse-Joulin², Silvia Magni-Manzoni³, Ana Narrodi⁴, Nikolay Tzaribachev⁵, Annamaria Iagnocco⁶, Esperanza Naredo⁷, Maria-Antonietta d'Agostino⁸ and Paz Collado⁹, ¹University of Ottawa, Ottawa, ON, Canada, ²Rheumatology, CHU Brest, Brest, France, ³Ospedale Pediatrico Bambino Gesù, Roma, Italy, ⁴Rheumatology, Madrid, Spain, ⁵Pediatric Rheumatology, Center for Rheumatic Diseases, Bad Bramstedt, Germany, ⁶Sapienza University of Rome, Rome, Italy, ⁷Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ⁸Rheumatology, Ambroise Paré Hospital, and Versailles Saint Quentin en Yvelines University, Boulogne-Billancourt, France, ⁹Rheumatology, Severo Ochoa University Hospital, Madrid, Spain
Background/Purpose: Musculoskeletal ultrasound (MSUS) has significant potential in the assessment of disease activity and early structural damage in childhood arthritides. In order to assess pathology,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].